BMS-986020
- Generic Name
- BMS-986020
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C29H26N2O5
- CAS Number
- 1257213-50-5
- Unique Ingredient Identifier
- 38CTP01B4L
- Background
BMS-986020 is under investigation in clinical trial NCT02017730 (To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers).
- Associated Conditions
- -
- Associated Therapies
- -
A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2016-07-22
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT02588625
- Locations
- ๐ฌ๐ง
Local Institution, London, Greater London, United Kingdom
A Phase 1 Drug-drug Interaction Study in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2014-08-27
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 20
- Registration Number
- NCT02227173
- Locations
- ๐บ๐ธ
Healthcare Discoveries, LLC d/b/a ICON Development Solutions, San Antonio, Texas, United States
Drug Interaction Study With Rosuvastatin
- Conditions
- Interventions
- First Posted Date
- 2014-04-01
- Last Posted Date
- 2014-06-17
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 26
- Registration Number
- NCT02101125
- Locations
- ๐บ๐ธ
Healthcare Discoveries, Llc D/B/A Icon Development Solutions, San Antonio, Texas, United States
To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2015-07-07
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 20
- Registration Number
- NCT02017730
- Locations
- ๐บ๐ธ
Yale Pet Center, New Haven, Connecticut, United States
Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2013-01-11
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 325
- Registration Number
- NCT01766817
- Locations
- ๐บ๐ธ
Weill Cornell Medical College, New York, New York, United States
๐บ๐ธCleveland Clinic Florida- Weston Hospital, Weston, Florida, United States
๐ต๐ชLocal Institution, Lima, Peru
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.